Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole injection for bleeding gastric ulcers
CTR20160229Phase 2Active
- Sponsor
- Yuekang Pharmaceutical Group
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lansoprazole in Peptic ulcer disease (PUD), gastric ulcer, duodenal ulcer, upper gastrointestinal bleeding (UGIB), sponsored by Yuekang Pharmaceutical Group. Started Oct 2016; status: active.
02
Drugs
lansoprazole
03
Conditions
Peptic ulcer disease (PUD)gastric ulcerduodenal ulcerupper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on CTR20160229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160229.